Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1704-2026

Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Recall

Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Model/Catalog Number: FS252251502 Product Description: 5 French sheath, 0.014" guidewire compatible over-the-wire injectable angioplasty balloon catheter, balloon diameter 2.5mm, balloon length 225mm, catheter working length 150cm Component: NA

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1704-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 21, 2025
FDA report date
Apr 8, 2026
Quantity in commerce
22 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon Catheter Model/Catalog Number: FS252251502 Product Description: 5 French sheath, 0.014" guidewire compatible over-the-wire injectable angioplasty balloon catheter, balloon diameter 2.5mm, balloon length 225mm, catheter working length 150cm Component: NA

Affected model & UDI checker

Search the exact identifiers published for Z-1704-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
FS252251502Brand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon CatheterCheck source noticeNot specified
Not specifiedBrand Name: Finesse BTK Multicath Product Name: Injectable Angioplasty Balloon CatheterCheck source notice00810017490967
FDA code information

Model/Catalog Number: FS252251502; UDI-DI: 00810017490967; lots: 240502, 240095, 231296, 231296A and 240095A;

View the original FDA recall notice

Why was this product recalled?

Potential for the balloon in the device to not meet burst specifications.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did SUMMA THERAPEUTICS, LLC take?

On July 21, 2025, customers were notified via E-mail. We discovered that the burst test values recorded did not meet the specification of the safety rated burst test average of 17atm. Please review your inventory and we ask that these catheters be returned for further investigation.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology